Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-24

Clinical Trial Update: Efficacy and Safety of Lactoferrin in Heart Failure Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of lactoferrin in patients with heart failure with reduced ejection fraction. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)

Snippet

Sponsor: Cairo University | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: NOT_YET_RECRUITING